How melatonin signals day and night: the pineal hormone of darkness

The pineal gland's hormone of darkness

The pineal gland is a small, pinecone-shaped endocrine gland tucked near the center of the brain, in a region called the epithalamus. Its best-known product is melatonin, a hormone it releases into the bloodstream and the surrounding cerebrospinal fluid. Melatonin is frequently called the "hormone of darkness" because its levels rise at night and fall during the day.

The central idea is that melatonin is a timing signal rather than a sedative in the everyday sense. It behaves like a chemical readout of the environmental light-dark cycle, and the body uses its nightly rise and daytime fall to broadcast information about the time of day, and the length of the night, to tissues throughout the body. Notably, this nocturnal pattern appears in both day-active and night-active animals, which is why researchers describe melatonin as a signal of darkness itself rather than of sleep.

Because the rhythm is so tightly bound to darkness, the melatonin curve is sometimes described as a hand of the biological clock, or the "chemical expression of night." Understanding how it works means following three connected threads:

• How the pineal gland assembles the molecule
• How light controls when it is released
• How the MT1 and MT2 receptors allow the rest of the body to read the message

From serotonin to melatonin: how the pineal gland builds it

Melatonin is an indoleamine, a class of molecules built from the amino acid tryptophan. Inside the pineal gland's cells (pinealocytes), tryptophan is first converted to 5-hydroxytryptophan and then to serotonin. In other words, the familiar neurotransmitter serotonin is the direct chemical precursor of melatonin, and the two sit on the same biosynthetic pathway.

Two enzyme steps turn serotonin into melatonin. First, an enzyme called arylalkylamine N-acetyltransferase (AANAT) attaches an acetyl group to serotonin, producing N-acetylserotonin. Then a second enzyme, ASMT (also known as HIOMT), adds a methyl group to form melatonin. AANAT is the rate-limiting step, and its activity swings dramatically between day and night, which has earned it the nickname "the timezyme." When AANAT activity climbs after dark, melatonin output climbs along with it.

This is why the pineal gland can produce melatonin on such a precise schedule. Rather than storing a reservoir and releasing it on cue, the gland ramps its synthesis machinery up and down. Melatonin is fat-soluble and is not stockpiled; once made, it diffuses out of pinealocytes almost immediately and enters the circulation. As a result, the nightly profile of melatonin in the blood closely tracks the nightly activity of the AANAT enzyme.

Why light switches the signal off

In humans, the pineal gland does not sense light directly. The light information that governs it begins in the retina, where a specialized group of cells known as intrinsically photosensitive retinal ganglion cells (ipRGCs) carry a pigment called melanopsin. These cells respond directly to light, and they are especially sensitive to short-wavelength, blue-enriched light near 480 nanometers. Unlike rods and cones, their role is less about forming detailed images and more about reporting the overall level of ambient light.

These retinal cells send their signal along the retinohypothalamic tract to the suprachiasmatic nucleus (SCN) of the hypothalamus, the brain's master circadian clock. From the SCN, a multi-step nerve pathway descends to the spinal cord, passes through the superior cervical ganglion, and returns as sympathetic nerve fibers that reach the pineal gland. At night, these nerves release norepinephrine onto pinealocytes; this engages beta-adrenergic receptors, raises the second messenger cAMP, and drives AANAT activity, effectively switching synthesis on.

Light reverses this chain of events. When the ipRGCs report light to the SCN, the SCN suppresses the downstream sympathetic drive to the pineal gland. Norepinephrine release falls, AANAT activity drops, and melatonin production is turned down. This is the mechanism by which light exposure, including artificial light in the evening, is understood to suppress melatonin release: the retina-to-SCN-to-pineal circuit reads incoming photons and gates the synthesis pathway accordingly.

The wavelength of the light matters to this circuit. Because melanopsin responds most strongly to blue-enriched light, research describes short-wavelength light as particularly effective at suppressing melatonin, and this is one reason evening light environments are a recurring topic in circadian science. This is a description of how the pathway is understood to respond to light, not guidance about any particular lighting or product.

MT1 and MT2 receptors read the signal

Once melatonin is circulating, cells detect it through two G protein-coupled receptors, named MT1 (encoded by the gene MTNR1A) and MT2 (encoded by MTNR1B). Both are high-affinity receptors, and when melatonin binds them they typically couple to Gi proteins, which lowers intracellular cAMP. These receptors are found in many tissues, but one of the most important sites is the suprachiasmatic nucleus itself.

This arrangement creates a feedback loop. The SCN drives the nightly melatonin rhythm, and the melatonin that results acts back on SCN neurons through MT1 and MT2. Research generally associates MT1 with acutely quieting the electrical firing of SCN neurons, and MT2 with shifting the phase, or timing, of the clock. Through these two receptors, melatonin is understood to feed time-of-night information back to the master clock and outward to peripheral tissues.

Because of this, melatonin is often described as a chronobiotic, a molecule that carries timing information, rather than as a simple sedative. Its receptors are read as an "it is night" and "the night is this long" message. MT1 and MT2 are expressed in numerous tissues beyond the brain, including the retina and blood vessels, which is how a single hormone can distribute a coordinated darkness-and-timing cue across the whole system.

The duration of the nightly melatonin signal also carries information in many species. Because the pineal gland raises melatonin only during darkness, a long winter night produces a longer melatonin pulse than a short summer night. Comparative research describes this as a "melatonin as calendar" role, in which the length of the melatonin signal conveys the season, or photoperiod, to the animal's physiology.

Melatonin as one output of the body clock

It helps to place melatonin within the larger circadian system. The SCN keeps roughly 24-hour time using a molecular feedback loop of clock genes, including CLOCK, BMAL1, PER, and CRY, whose proteins rise and fall over about a day. Light entrains, or resets, this loop each day so that internal time stays aligned with the external day. Melatonin is one of the clock's outputs, not the clock's engine.

Because the melatonin rhythm is robust and relatively easy to measure, the timing of the evening rise, known as dim-light melatonin onset, is widely used in research as a marker of a person's internal clock phase. In other words, scientists read melatonin as a reliable indicator of where the clock is currently set, which is different from saying melatonin sets the clock on its own.

This distinction clarifies what the molecule actually does. Melatonin does not so much create night inside the body as report it. The pineal gland reads the SCN, the SCN reads the retina, and the retina reads the light. Melatonin is the messenger at the end of that chain, and the MT1 and MT2 receptors are how the rest of the body receives the message.

An educational overview, not medical advice

This article describes how melatonin signaling is currently understood in physiology and chronobiology. It is educational only and is not medical advice, a diagnosis, or a recommendation to use any product. It intentionally does not cover dosing, timing, schedules, or how any preparation should be used, because those are clinical decisions that depend on an individual's full health picture.

Any decision about a sleep-related medication or supplement belongs to a licensed provider who can evaluate a person's history, other medications, and circumstances. Compounded medications are not FDA-approved products, and statements about them have not been evaluated by the Food and Drug Administration. On OpenDoseRx, prescription products are dispensed only after review by an independent, licensed U.S. provider, and nothing here replaces a conversation with your own clinician.